SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease, has been designated…
Read More
San Clemente, Calif., July 30th, 2019–(BUSINESS WIRE) — Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER…
San Clemente, Calif., April 10th, 2019–(BUSINESS WIRE)– Reflow Medical, Inc. has announced the completion of enrollment in its Wing-IT investigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the…
Non-Randomized Study Evaluating the Use of the Reflow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries) SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical Inc., a developer of innovative medical devices…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)— Reflow Medical, Inc., a developer and innovator of crossing and support catheters for use in the treatment of occlusive cardiovascular disease, announced that the company has…
San Clemente, Calif.–(BUSINESS WIRE)—ReFlow Medical Inc. announced the issuance of U.S. Patent No. 9,204,893 entitled, “Systems, Methods, and Devices for Ablation, Crossing, and Cutting of Occlusions” for its innovative Wingman...
Read More
SAN CLEMENTE, Calif.–(BUSINESS WIRE)—ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their speX™ Shapeable Support Catheter for use in the peripheral vasculature as well as the first...
Read More
(L) John R. Laird, Jr., MD, is an Interventional Cardiology and Cardiology specialist in St. Helena, CA. (R) Mahmood K. Razavi, MD, specializes in Radiology, Vascular and Interventional Radiology in...
Read More
SAN CLEMENTE, Calif.–(BUSINESS WIRE)—ReFlow Medical, Inc. (ReFlow) today announced the initial clinical use of their Wingman35 Crossing Catheter and speX™ Shapeable Support Catheter by Dr. Andrej Schmidt at University Leipzig, Germany….
ReFlow Medical, Inc. today announced that it has signed an exclusive distribution and sales agreement for ReFlow’s suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo),...
Read More
Recent Comments